Wales' education minister Kirsty Williams will give an update today on when schools here will start to open more widely.

The Brecon and Radnorshire MP will lead Wales' daily briefing at 12.30pm in Cathays Park and is expected to reveal her plans to start bringing back pupils to schools and smaller children to nurseries. We'll be covering this live here.

We'll also have live updates from Westminster where where Boris Johnson faces Keir Starmer at Prime Minister's Questions from noon and Home Secretary Priti Patel will lay out her plans for new quarantine restrictions on people arriving in the UK.

Our education editor Abbie Wightwick has looked at the options she is thought to be considering, which include schools starting back again on either June 22 or June 29 - albeit in a staggered way starting with only some age groups.

The deaths of seven more people with coronavirus were reported in Wales on Tuesday, to take the daily total published by Public Health Wales to 1,354.

However the true total has already passed 2,122, according to the latest more detailed figures which were published by the Office for National Statistics on Tuesday. These only cover the period up to May 22.

England's Health Secretary Matt Hancock said there is more work to do to find out why people from ethnic minority backgrounds are more at risk from coronavirus. A major review found people of Bangladeshi ethnicity are twice as likely to die.

Earlier on Tuesday, Health Minister Vaughan Gething warned that coronavirus could return to Wales "with a vengeance" and that lockdown measures could start again in the winter if it does.

We'll have live updates below. You can see our live coverage from Tuesday's press conferences here.

Live updates below:

First child to receive treatment with blood plasma

A child has become the first patient to receive a transfusion of plasma from people who have recovered from coronavirus through a dedicated treatment trial.

Scientists say the randomised evaluation of Covid-19 therapy (recovery) trial tests existing treatments that may help people hospitalised with suspected or confirmed cases of the virus.

The randomly-selected patient is the first of any age to be transfused with Covid-19 convalescent plasma through the recovery trial, according to NHS Blood and Transplant (NHSBT).

The transfusion took place at the Royal Manchester Children's Hospital and the patient, who is under the age of 18, is also the first child to receive plasma through the NHSBT plasma programme.

Although patients have already received plasma through the REMAP-CAP trial, this was not focused solely on coronavirus and only adults in intensive care were able to receive the treatment, according to NHSBT.

Universities may make students live in a bubble

Universities are considering making students live in a "bubble" with people on the same courses to limit social mixing when campuses reopen in the autumn.

Students arriving at university for the first time could be faced with virtual freshers' week events, fewer large-scale lectures and one-way systems across campus in a bid to keep them safe.

A series of proposals for easing out of lockdown safely have been unveiled by university leaders - including using a "blended" learning approach, with a mix of online and face-to-face classes.

It comes after a poll from the University and College Union (UCU) found that 71% of applicants would prefer to delay the start of the academic year if they could get more face-to-face teaching.

Ibuprofen could treat coronavirus

A new trial has been launched to assess whether ibuprofen may hold the key to preventing severe breathing problems in Covid-19 patients.

Experts are assessing whether a special formulation of the cheap drug could help reduce the serious side effect seen among patients infected with the novel coronavirus.

At the start of the pandemic it was thought that the anti-inflammatory drug could exacerbate the disease but it is now hoped that a special formulation will reduce severe respiratory illness.

This could potentially lead to shorter hospital stays and fewer patients needing help in intensive care units (ICU).

Mitul Mehta, professor of neuroimaging and psychopharmacology and director of Centre for Innovative Therapeutics at Kings College London, told the PA news agency: "It's a trial for patients with Covid-19 disease to see if giving them an anti-inflammatory drug - a specific form of ibuprofen - will reduce the respiratory problems they have."

Simplify coronavirus warnings, says Blair

The UK's "confusing array" of lockdown phases, steps and alert levels should be replaced by a "simple" alert system, Tony Blair's think tank has recommended.

A report by the former prime minister's Institute for Global Change said the various measures for outlining the risk posed by coronavirus "substantially overlap" with one another.

Mr Blair was only referring to the UK Government's five-tiered Covid-19 alert level system, three steps for easing lockdown measures, three recovery phases and five tests for adjusting the restrictions.

On top of that Wales has its own traffic light system, it's own lockdown easing questions and schools reopening tests.

The report said the measures are "poorly defined and assessed in opaque ways, and are not linked explicitly to the lifting of different restrictions".

Instead, it called on ministers to simplify and rationalise the "array of tests, alerts and steps".

Lockdown heightens education divide

Covid-19 is widening the attainment gap between disadvantaged children and their better-off peers, a study suggests.
Analysis by the Education Endowment Foundation (EEF) - which looked at various reasons for school shutdowns ranging from summer holidays, adverse weather, teacher industrial action, natural disasters - estimate the gap could widen from 11% to 75%.
Over the past decade the attainment gap between disadvantaged pupils and their classmates at the end of primary school is estimated to have narrowed, from 11.5 months in 2009 to 9.2 months in 2019, according to the Education Policy Institute.
The EEF fears that progress made since 2011 will be reversed.

Government 'can't handle Brexit and coronavirus together'

The Government may struggle to run effective public information campaigns on coronavirus and the end of the Brexit transition at the same time, MPs have warned.
The Commons Public Accounts Committee said there was a danger important messaging on the need to prepare for the new arrangements with the EU will be "crowded out" if the focus is still on Covid-19.
Boris Johnson has been adamant he will not seek any extension to the current transition period which ends on December 31, despite warnings the coronavirus outbreak means it will be impossible to conclude a new free trade agreement with the EU by then.
The committee said it was "vital" that citizens and businesses were well prepared for the changes that the end of the transition will entail.

Leaders face off at PMQs

Boris Johnson is expected to face Sir Keir Starmer at Prime Minister's Questions for the first time since news emerged of the controversial lockdown trip made by Dominic Cummings.
All eyes will be on the House of Commons at midday to see how the Prime Minister performs opposite the Labour leader, with Mr Johnson likely to be grilled over his support for his senior adviser over his decision to take his family 260 miles away to Durham in March to self-isolate.
The leaders will come face to face on the day the UK coronavirus death toll could reach 50,000, having passed 49,800 on Tuesday.
Meanwhile, new quarantine restrictions on travellers arriving in the UK will be set out by Home Secretary Priti Patel on Wednesday, including requiring the majority of visitors to Britain to self-isolate for 14 days.

Questions about hydroxychloroquine study

The Lancet has raised concerns about a study it recently published that prompted the World Health Organisation to suspend trials of two anti-malarial drugs as a potential Covid-19 therapy.
The paper, published on May 22, found hydroxychloroquine and chloroquine had been linked to increased risk of death and heart arrhythmias among people admitted to hospital with coronavirus.
US President Donald Trump has been criticised for promoting the drugs - which are used to treat malaria, arthritis and lupus - as a cure for the new virus.
The authors of the study said neither drug should be used to treat Covid-19 outside of clinical trials and said randomised clinical trials were needed.
The findings prompted the WHO to suspend hydroxychloroquine testing within Covid-19 drug trials as a precaution to allow the safety data to be reviewed.
But on Tuesday evening, the Lancet's editors published an "expression of concern" and said "important scientific questions" had been raised about the data used in the study.

Huge rise in benefits claims

Ministers are considering doubling the number of frontline staff dealing with Universal Credit to cope with the increase in demand since the coronavirus outbreak.
Work and Pensions Secretary Therese Coffey told peers her department could need twice its current cohort of 13,500 work coaches - a staff member assigned to assist claimants in finding work - to deal with the sheer volume of benefit applications.
Benefit claims in the UK soared by more than 69% in April as the coronavirus lockdown gripped the labour market.
The Office for National Statistics (ONS) said that claims under Universal Credit by the unemployed and those on low incomes surged by a record 856,000 to 2.1 million in April, compared with the previous month.